SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 30.71+3.0%Dec 8 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16057)9/11/2002 3:08:15 PM
From: Cacaito  Read Replies (1) of 17367
 
Not bad at all, it just took you 21 hours to figure it out!

Blue, Dna is a dissapointment for long time, I only hold 100 shares after disposing of about 95% of my position long ago at a decent profit.

It is so low that from now on it should be only positive, but Tarceva is not so hot, Xolair is in retrials, Avastin just failed (pending the main indication in Colon Ca), and the market does not care about Raptiva with Dna (only xoma moves with Rap news).

I keep looking for entry point at Dna and keep finding that it is lower than previous point. Maybe is time, but just for long term. At this rate maybe Biogen could end up buying them up (and divest Rap to xoma to avoid antitrust rules).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext